Nanoparticle-based delivery systems for vaccines

Rajashri Bezbaruah, Vivek P Chavda, Lawandashisha Nongrang, Shahnaz Alom, Kangkan Deka, Tutumoni Kalita, Farak Ali, Bedanta Bhattacharjee, Lalitkumar Vora

Research output: Contribution to journalReview articlepeer-review

60 Downloads (Pure)


Vaccination is still the most cost-effective way to combat infectious illnesses. Conventional vaccinations may have low immunogenicity and, in most situations, only provide partial protection. A new class of nanoparticle-based vaccinations has shown considerable promise in addressing the majority of the shortcomings of traditional and subunit vaccines. This is due to recent breakthroughs in chemical and biological engineering, which allow for the exact regulation of nanoparticle size, shape, functionality, and surface characteristics, resulting in improved antigen presentation and robust immunogenicity. A blend of physicochemical, immunological, and toxicological experiments can be used to accurately characterize nanovaccines. This narrative review will provide an overview of the current scenario of the nanovaccine.

Original languageEnglish
Article number1946
Issue number11
Publication statusPublished - 17 Nov 2022


  • nanoparticles
  • Nanovaccine
  • exosome


Dive into the research topics of 'Nanoparticle-based delivery systems for vaccines'. Together they form a unique fingerprint.

Cite this